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This thesis aims to defi ne the diagnostic algorithm for chronic discogenic low back 
pain (CD-LBP) and to assess the evidence for minimally invasive treatments for CD-LBP, 
including the reproduction of a randomized controlled trial on the eff ect of intradiscal 
methylene blue injection on CD-LBP.
 Background 
Low back pain is a major and growing problem worldwide. The Global Burden of Diseases, 
Injuries and Risk factor study (20171) showed that low back pain is the number one cause 
of years lived with disability. This burden poses considerable challenges to health systems 
and economies.2, 3
Low back pain has a multifactorial origin. In approximately 40% of the cases, LBP appears 
to be of discogenic origin.4, 5 The sacroiliac (SI) joint or the facet joints are indicated as the 
cause of LBP in 13% and 15-40% of the cases, respectively. In clinical practice often more 
than one cause can be found simultaneously.5
Figure 1: Importance of low back pain as leading cause of age-standardized years lived with 
disability rated by location, for both sexes combined, 2017. From Global Burden of Disease 1 free of 
copyright. 
Discogenic low back pain, although attributed to a degenerative process, may improve 
spontaneously over time. For patients presenting with discogenic low back pain 
conservative management, consisting of medication and a multidisciplinary rehabilitation 
program that focusses on reducing pain and provides instructions on posture and body 
movement, is recommended fi rst. 
The World Health Organization (WHO) uses a stepwise approach to the pharmacological 
treatment of pain.6 The last decades reports on the increasing number of opioid deaths 
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and addiction, especially in the population of non-cancer pain sufferers, justify a critical 
assessment of the advantages and disadvantages of long-term opioid use. Recent 
guidelines on the treatment of low back pain discourage to use opioids for managing 
chronic low back pain.7 The development of anti-neuropathic medication added another 
dimension to the treatment algorithm dividing pain into mechanical pain, neuropathic 
pain or combined pain syndromes.
The selection of a minimally invasive treatment option can only be made when the pain 
source is identified. In patients with chronic mechanical low back pain, the facet and 
sacroiliac joints as pain generators should first be excluded, before the intervertebral 
disc can be suspected as a pain generator.8 Disc degeneration and pathologies can best 
be visualized with Magnetic Resonance Imaging (MRI) in T1 and T2 setting.9 Desiccation, 
loss of height, high-intensity zones (HIZ) and Modic signs can be visualized. However, 
radiologic findings correlate poorly with the clinical presentation. It is well known that 
asymptomatic discs may appear abnormal on MRI, while normal appearing discs have 
been shown to be painful on provocation.10 
The inconsistency of history, physical examination, and radiographic findings leaves the 
critical question: “How can the diagnosis of discogenic low back pain be made?” 
Provocative discography may provide the link in diagnosing suspected discs as the origin 
of low back pain. The answer is a technique that combines imaging, intradiscal pressure, 
and pain reproduction, together with morphologic abnormalities observed on MRI. 
This test can be indicative of the discogenic origin of low back pain.11 Discography is an 
invasive procedure and long term follow up of discography patients has demonstrated 
acceleration of disc degeneration.12 It was demonstrated in degenerative porcine discs 
that pressure transfer to the adjacent disc happens during discography.13 
Although it has yet to be demonstrated that any targeted intervention can reliably treat 
discs, identified as the anatomic source of pain by provocative discography, it is argued 
that there is a place for discography as a diagnostic utility.14, 15 
A good diagnostic test offers the patient a source for their pain, the best patient selection 
for the treatment of CD-LBP and possibly the best treatment results.
The answers found for the research questions formulated for this thesis, aim at improving 
diagnosis and selection of the most appropriate minimally invasive treatment strategy for 
patients with CD-LBP.
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Research question1: 
What is the current evidence for minimally invasive treatments in discogenic low back 
pain: A systematic review of the literature?
Chapter 2a summarizes the literature relative to the diagnosis and treatment of discogenic 
pain up till 2010.8 
In Chapter 2b we present the update of the evidence for the interventional pain 
management options based on the literature up to March 2018. This review showed 
evidence of moderate quality for intradiscal biacuplasty, resulting in a moderate strength 
of recommendation for its use in a highly selected patient group with CD-LBP. The 
randomized controlled study on the effect of intradiscal methylene blue injection was 
judged to be of moderate quality: its criticisms and the lack of reproduction of the results, 
justified a weak recommendation. Intradiscal electrothermal therapy was supported by 
evidence of low quality.
Research question 2: 
Is the pressure transfer to an adjacent disc in disc stimulation real and significant?
Recently, an in vivo porcine study and a study in nine human subjects showed pressure 
transfer to the adjacent discs during discography. This could mean that the concordant 
pain the patient describes originates from an adjacent disc.13, 16
In chapter 3 we describe a cohort of patients in which during provocative discography 
pressure was measured in adjacent discs.17
Fifty patients were selected with suspected CD-LBP. An arterial blood pressure monitoring 
system simultaneously assessed the pressure in the adjacent discs while low-speed flow, 
pressure-controlled discography was performed on the suspected discs.
In patients with a positive discography, the average intradiscal peak pressure was 15.1psi 
(SD-11.1). In 48 procedures, no pressure rise in the adjacent discs was found. A small, but 
not clinically relevant rise (1.1 psi) in the adjacent disc during discography was recorded 
in 2 patients.
The pressure rise in adjacent discs does not seem to occur during low-speed flow pressure-
controlled provocation discography in human discs. False-positive pain reaction caused 
by potentially painful adjacent discs are therefore unlikely during low-speed flow (low) 
pressure-controlled discography. 
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Research question 3: 
What is the place of intradiscal methylene blue injection in patients with CD-LBP?
In chapter 4 we describe the results of a prospective case-cohort study of the intradiscal 
injection of methylene blue in CD-LBP.18
Patients were carefully selected on clinical criteria, magnetic resonance imaging, and a 
positive provocative discography. 
Copying the protocol of Peng et al.,19 15 consecutive patients, were injected with 1 ml of 
methylene blue 10%, 1 ml lidocaine 1% and 0.5 ml of contrast dye.
Patients were recruited in two interventional pain treatment centers of the Netherlands. 
Six months after the intervention, 40% of the patients claimed at least 30% pain relief. 
In patients who responded, physical function improved, and medication use diminished. 
These patients were defined as responders. We observed no complications or adverse 
events.
These findings justified the set up of a randomized, double-blind, placebo-controlled trial.
In chapter 5 we describe the results of the multicenter randomized controlled trial on the 
efficacy of intradiscal methylene blue (MB) injection for CD-LBP: the Intradiscal Methylene 
Blue Injection (IMBI) study.20
In this RCT, the design of the previously published study by Peng et al.19 was replicated. A 
multicenter RCT was performed to assess whether the extraordinary effect of intradiscal 
MB on pain intensity could be confirmed. Success was defined as at least a 30% reduction, 
in pain intensity and the Patients’ Global Impression of Change (PGIC) 6 months after the 
intervention. To include 84 patients, we screened 1364 patients. Patients were excluded 
from participation because of successful test block of the facet joints (n=191), suffering 
from a pain syndrome different from CD-LBP (n=409), not fulfilling other inclusion 
and exclusion criteria (n=177), refusing to participate in the study (n=248), negative 
discography (n=155) and other reasons (n=100). 
Although we exactly replicated the study protocol by Peng et al.19 we were unable to 
reproduce their effect size. We included 84 patients with CD-LBP of which 14 (35%) in the 
MB +lidocaine group showed treatment success compared with 11 (26,8%) in the control 
group who received isotonic saline plus lidocaine (P=0.43). Twenty-seven percent of all 
participants treated with MB stated that their overall health improved much or very much 
vs 26% in the control group (P=0.96).
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We were unable to confirm that intradiscal MB injections reduced pain significantly in 
patients with CD-LBP 6 months after treatment compared with placebo. As a remarkable 
finding, we observed that over one-quarter of patients receiving only lidocaine injections 
reported treatment success, which is in contrast with the previously published study. 
We recommend further research to study the exact mechanisms of CD-LBP and to define 
specific characteristics of subgroups of patients with CD-LBP to determine whether 
intradiscal injections (with MB or lidocaine 1%) may be a treatment option.
At present we do not recommend the routine use of intradiscal MB for CD-LBP.
Research question 4: 
Is there a place for spinal cord or DRG stimulation in patients with CD-LBP?
Failed Back Surgery Syndrome (FBSS) is defined as a surgical end stage after one or more 
interventions on the (lumbar) spine, without persisting effect.
Spine surgeons do not describe this situation anymore as FBSS but “persisting or recurrent 
pain” after spine surgery.
A systematic review of the literature21 and an RCT22 demonstrated that spinal cord 
stimulation (SCS) is effective for the treatment of FBSS. An RCT compared SCS with 
reoperation.23 Patients selected as candidates for reoperation after spine surgery were 
randomly assigned to reoperation or SCS. If the results of the randomized treatment 
were unsatisfactory, patients could cross over to the alternative treatment. SCS was more 
effective than reoperation and fewer patients initially treated with SCS crossed over to 
surgery than vice versa. 
Recently a special electrode allowing to stimulate the dorsal root ganglion (DRG) became 
available. Stimulation of the DRG is thought to produce targeted stimulation and optimal 
paresthesia coverage of the painful area compared with SCS.24 The innervation of the 
discs is provided by the sinu-vertebral nerves and the rami communicantes, which are 
sympathetic nerves. The sinu-vertebral nerve is implicated in diffuse low back pain. 
It cannot directly reach the somatic element of each level of the lumbar spine.25 The 
cutaneous innervation from L3 to L5 must therefore, pass through the nearest somatic 
nervous system structure, which is the spinal ganglion L2. (see figure 2) Therefore, the 
bilateral DRG L2 is considered a target for interventional pain treatment. 
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Figure 2: Innervation of the discus intervertebralis. 
Rogier Trompert Medical Art. http://www.medical-art.eu.
In chapter 6, we describe the results of DRG stimulation in a group of patients with FBSS. 
We found that DRG L2 stimulation improves low back pain, function, and quality of life of 
FBSS patients.26
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This study is a multi-center single arm observational cohort study of patients with 
persisting back and leg pain after lumbar spine surgery. Patients failed conservative and 
minimally invasive treatments. 
Thirteen patients underwent a trial of DRG stimulation. Good paresthesia coverage of the 
painful area in the low back region was typically achieved with L2 stimulation, the majority 
of the DRG leads for leg pain were placed at L4-L5 level to cover chronic neuropathic 
leg pain. Eleven patients had good results and underwent implantation of a permanent 
neurostimulator. The pain was reduced from 8.64 (±0.92) at baseline to 2.40 ( ±2.38 n=9) 
after 12-months of treatment, a 72.05% reduction. Similar improvements were observed 
looking at secondary clinical outcome measures.
These results suggest that DRG stimulation induces pain relief in patients diagnosed with 
FBSS.
An interesting finding was the substantial effect of DRG L2 stimulation on chronic 
neuropathic low back pain.
In chapter 7, we describe a prospective pilot study (non-responders from the IMBI RCT 
after 24 months) who received DRG L2 stimulation27
This study was launched to investigate the utility of DRG stimulation at the L2 spinal level 
for patients with CD-LBP who had not undergone previous back surgery.
Twenty patients with confirmed discogenic pain, and no prior history of back surgery, 
underwent trials of DRG stimulation (bilateral DRG L2) and were permanently implanted 
when pain relief of at least 50% was achieved.
Treatment with DRG L2 stimulation for CD-LBP reduced LBP pain rating (68.3% reduction), 
from mean 7.20±1.3 at baseline to 2.29±2.1 after 12-months (p=<0.001). Oswestry 
disability ratings significantly decreased from 42.09±12.9 at baseline to 21.54±16.4 after 
six months of treatment and to 20.1±16.6 after 12-months of treatment. The average 
quality of life EQ-5D index score at baseline was 0.61±0.12 and 0.84±0.13 after 12-months. 
The outcomes of DRG stimulation in the treatment of CD-LBP are very promising but 
these are the first results in a small prospective study. These results should be reproduced 
in a large trial and compared to conventional spinal cord stimulation also looking at the 
cost-effectiveness and invasiveness of the procedure.
In every patient, a comparative assessment should be made of the invasiveness of a 
procedure against the health profit to be gained.
